CIK 0001761612
- Non-accelerated filer
- Smaller reporting company
BICYCLE THERAPEUTICS PLC
Sign in to watch- Ticker
- BCYC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- Operating
- Phone
- +44 1223261503
- Business address
- BLOCKS A & B, PORTWAY BUILDING, GRANTA PARK, GREAT ABINGTON, CAMBRIDGE, United Kingdom, CB21 6GS
- Former names
- BICYCLE THERAPEUTICS Ltd
- 4 Grant or award Director acquired 24,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale CHIEF PROD & SUPPLY CHAIN OFF sold 257 shares at $22.49 ($5,780)
- 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 3,158 shares at $23.81 ($75,192)
- 4 Open-market sale CHIEF TECHNOLOGY OFFICER sold 955 shares at $23.81 ($22,739)
- 4 Open-market sale CHIEF OPERATING OFFICER sold 955 shares at $23.81 ($22,739)
- 4 Open-market sale CHIEF BUSINESS OFFICER sold 955 shares at $23.81 ($22,739)
- 4 Open-market sale CHIEF SCIENTIFIC OFFICER sold 790 shares at $23.81 ($18,810)
- 4 Open-market sale CHIEF ACCOUNTING OFFICER sold 152 shares at $23.81 ($3,619)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 12,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award CHIEF DEVELOPMENT OFFICER acquired 21,660 shares (grant or award)
- 4 Open-market sale Chief Accounting Officer sold 604 shares at $17.50 ($10,570)
- 4 Grant or award Director acquired 12,000 shares (grant or award)
- 4 Open-market sale Chief Scientific Officer sold 2,640 shares at $17.50 ($46,200)
- 4 Grant or award Director acquired 6,000 shares (grant or award)
- 4 Grant or award Director acquired 6,000 shares (grant or award)
- 4 Grant or award Director acquired 6,000 shares (grant or award)
Page 6 of 16 · 304 filings